• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CareTrust REIT Inc. filed SEC Form 8-K: Other Events

    5/14/25 4:01:22 PM ET
    $CTRE
    Real Estate Investment Trusts
    Real Estate
    Get the next $CTRE alert in real time by email
    false0001590717CANYSE00015907172025-05-142025-05-14

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    FORM 8-K

     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): May 14, 2025

    CareTrust REIT, Inc.
    (Exact name of registrant as specified in its charter)


    Maryland
    001-36181
    46-3999490
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
     
     
    905 Calle Amanecer, Suite 300,
    San Clemente, CA
     
    92673
     
     
    (Address of principal executive offices)
     
    (Zip Code)
     
     
    Registrant’s telephone number, including area code: (949) 542-3140
     
    Not Applicable
    (Former name or former address, if changed since last report.)

     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $0.01 per share
    CTRE
    New York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company   ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐




    Item 8.01. Other Events.
     
       As disclosed in the Current Report on Form 8-K filed by the Company on March 11, 2025, CareTrust REIT, Inc. (the “Company”) previously announced (the “Rule 2.7 Announcement”) pursuant to Rule 2.7 of the United Kingdom City Code on Takeovers and Mergers a firm intention to make a cash offer to acquire (the “Acquisition”), through its wholly-owned direct subsidiary, CR United Bidco Limited, the entire issued and to be issued ordinary share capital (other than Scheme Restricted Shares (as defined in the Rule 2.7 Announcement)) of Care REIT plc (“Target”).

       On May 8, 2025 (Pacific time), the Company closed the Acquisition.  The Acquisition was implemented by means of a court-sanctioned scheme of arrangement (the “Scheme”) under Part 26 of the United Kingdom Companies Act of 2006.  Pursuant to the Scheme, Target shareholders, other than Sanctions Disqualified Shareholders (as defined in the Rule 2.7 Announcement), will receive 108 pence in cash for each Target share they held, representing approximately $595.4 million, and, together with the assumption of Target’s net debt of approximately $245.1 million, represents a total purchase price of approximately $840.5 million.  Payments will be made in British pound sterling but are expressed in U.S. dollars based on the exchange rate of 0.75 GBP to 1.00 USD on May 9, 2025.

       The Company previously deposited $606.0 million in an escrow account to satisfy the purchase consideration in connection with the Acquisition. The deposit was funded partially by cash on hand and by borrowing an aggregate of $425.0 million under the Company’s existing unsecured revolving credit facility provided for under that certain Third Amended and Restated Credit and Guaranty Agreement, dated as of December 18, 2024, by and among the Company, CTR Partnership, L.P., KeyBank National Association as administrative agent, and certain other guarantors, lenders, arrangers, managers, syndication agents, and documentation agents that are parties thereto.

       The foregoing summary of the Acquisition is subject to, and qualified in its entirety by, the text of the Rule 2.7 Announcement, a copy of which was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on March 11, 2025.



     SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Date: May 14, 2025
     
    CARETRUST REIT, INC.
           
       
    By:
    /s/ William M. Wagner
         
    William M. Wagner
         
    Chief Financial Officer and Treasurer


    Get the next $CTRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTRE

    DatePrice TargetRatingAnalyst
    3/13/2025$31.00Hold → Buy
    Deutsche Bank
    1/2/2025$34.00 → $26.00Neutral → Underperform
    Wedbush
    12/9/2024$34.00 → $32.00Outperform → Market Perform
    BMO Capital Markets
    10/1/2024$28.00 → $34.00Equal Weight → Overweight
    Wells Fargo
    5/29/2024$26.00Neutral
    Wedbush
    1/30/2024$23.00Hold
    Deutsche Bank
    9/20/2023$23.00Buy
    Jefferies
    9/12/2023$19.00 → $23.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings